{"id":316942,"date":"2026-10-19T14:42:45","date_gmt":"2026-10-19T09:12:45","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316942"},"modified":"2026-10-19T14:42:45","modified_gmt":"2026-10-19T09:12:45","slug":"prescription-brand-surface-treatment-firm-and-milk-products-stocks-roadmap-keystone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/prescription-brand-surface-treatment-firm-and-milk-products-stocks-roadmap-keystone-list\/","title":{"rendered":"3 Prescription Brand, Surface Treatment Firm and Milk Products Stocks With a Strong Future Roadmap: Mankind Pharma, Grauer & Weil (India) and Heritage Foods"},"content":{"rendered":"

Mankind Pharma Rs 2,275.50, P\/E 47.91. Grauer & Weil Rs 78.83, P\/E 22.12. Heritage Foods Rs 405.40, P\/E 26.48. Closing prices of 14 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Prescription brand, surface treatment firm and milk products stocks with the clearest long-term roadmaps today include Mankind Pharma in branded formulations across chronic and acute therapies, a consumer healthcare arm and a large field force, Grauer & Weil in surface treatment chemicals and related industrial products and Heritage Foods in milk, curd and value-added dairy products sold across southern and other states. FY26 revenue growth was 14.8% at Mankind Pharma, 5.1% at Grauer & Weil and 9.3% at Heritage Foods. P\/E stands at 47.91 for Mankind Pharma (industry 37.59), 22.12 for Grauer & Weil (industry 36.60) and 26.48 for Heritage Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Prescription brand, surface treatment firm and milk products stocks give investors exposure to medicines, industrial chemicals and dairy bought every day. Volumes, pricing and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three prescription brand, surface treatment firm and milk products stocks: Mankind Pharma for branded formulations across chronic and acute therapies, a consumer healthcare arm and a large field force, Grauer & Weil (India) for surface treatment chemicals and related industrial products and Heritage Foods for milk, curd and value-added dairy products sold across southern and other states. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n